drugset / Trial / NCT05947604

DDI Study of Single Oral Dose of Acoziborole With Sequential Co-administration of Midazolam and Dextromethorphan

NCT05947604

Phase 1 Completed 20 enrolled Drugs for Neglected Diseases
Non-randomizedCrossoverOpen-labelOther

Summary

To assess Drug drug interactions between Acoziborole and Dextromethorphan and Midazolam in healthy male volunteers.

Timeline

Start
2023-02-09
Primary completion
2023-05-03
Completion
2023-05-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Acoziborole Small molecule 960 mg Oral
Subject Dextromethorphan Unknown 15 mg Oral
Subject Midazolam Small molecule 5 mg Oral